Lettre d'information mensuelle "Beyond the GAAP"
La lettre "Beyond the GAAP" est éditée par Mazars. C'est l'équivalent anglophone de la newsletter "DOCTR'In".
Beyond the GAAP no.140 - January 2020
For example, in March, the IASB is expected to publish a Discussion Paper on goodwill and impairment. While the IASB is unlikely to propose the reintroduction of amortisation of goodwill, it is expected to make proposals aimed at improving disclosures in the notes and reducing the cost of impairment testing.
Beyond the GAAP no.139 - December 2019
Beyond the GAAP no.138 - November 2019
With the year-end closure approaching, the IFRS Interpretations Committee has finally confirmed its decision on determining the lease term under IFRS 16 – a topic that has been the subject of much debate – and has rejected the idea of amending the new standard just before its application date.
This so-called “clarification” could have substantive impacts for groups that had previously used a legal approach to determining the lease term. They will be forced to change their estimates.
However, in light of the publication date of the Committee’s decision, and the time needed to implement such changes where necessary, they are presumably not required in the financial statements for 2019. If an entity is unable to make the required changes, it should provide detailed disclosures in the notes, as recommended by the French market regulator (AMF).
We will provide a more detailed account of the Committee’s final agenda decision in our next issue.